Skip to main content
. 2019 May 16;37(3):351–362. doi: 10.1590/1984-0462/;2019;37;3;00006

Table 1. Categorization of studies on epidemiological, microbiological and prevention aspects.

  • Author

  • Country

  • Year

  • Type of study

  • Number

Relevance for inclusion Results and conclusions
  • Torres SL 1

  • Brazil

  • 2015

  • Descriptive, cross-sectional study

  • 1.209

Epidemiological, clinical, death and vaccination aspects Increased incidence of pertussis and its complications
  • Lynfield R 2

  • USA

  • 2014

  • Editorial

  • -

Review of clinical, microbiological and epidemiological aspects Important disease in public health and reemergence in the 21st century
  • Cherry JD 3

  • USA

  • 2013

  • Editorial

  • -

Review of clinical aspects, prevention and control Epidemiological changes in infection and new prevention strategies
  • Matoo S 4

  • USA

  • 2005

  • Review

  • -

Review of epidemiological, clinical and molecular biology aspects Broad subject review, including other species of Bordetella
  • Belletini CV 5

  • Brazil

  • 2014

  • Retrospective study of case series

  • 222

Clinical, laboratory and radiological predictors for pertussis Cyanosis and lymphocytosis were independent predictors of pertussis in children up to six months of age
  • Zlamy M 6

  • Austria

  • 2016

  • Review

  • -

Virulence factors and prevention strategies Host-toxin interaction defines immunological vaccine modulation by natural infection
  • Korppi M 9

  • Finland

  • 2013

  • Editorial

  • -

Review of clinical picture and prevention Approach to disease improved over the past 50 years
  • SVS, MS 10

  • Brazil

  • 2014

  • Surveillance Protocol by Ministry of Health, Brazil

  • -

Official protocol, with changes in definitions and criteria Redefines case criteria and recommends preferential use of azithromycin
  • SVS, MS 12

  • Brazil

  • 2016

  • Surveillance Protocol by Ministry of Health, Brazil

  • -

Official protocol, in use in Brazil Update of concepts, case criteria and therapeutic recommendations
  • Review

  • -

Pertussis in children and adolescents: diagnosis, treatment and prevention Adolescents and adults and their importance in the chain of transmission. Recommends their immunization
  • McGirr A 14

  • Canada

  • 2015

  • Review

  • -

Duration of vaccine immunity Immunity conferred by DTP is longer lasting than DTPa
  • CGPNI, MS 15

  • Brazil

  • 2014

  • Technical report

  • -

Implantation of the dTpa vaccine Criteria and recommendations for use of the dTpa vaccine in adults
  • CDC recommendation

  • -

Prevention strategies Recommendation of vaccination of the pregnant woman with dTpa
  • SVS, MS 17

  • Brazil

  • 2016

  • Epidemiological Bulletin Descriptive study

  • 10.487

Analysis of the epidemiological situation of pertussis in Brazil, 2015 Epidemiological standard would not have changed in Brazil, continuing to undertake preferentially infants under the age of one.
  • SVS, MS 18

  • Brazil

  • 2015

  • Epidemiological Bulletin Descriptive study

  • 72.901

Analysis of the epidemiological situation of pertussis in Brazil, 2010-2014 Increased number of cases in Brazil due to cyclical behavior of the disease
  • Smith AM 19

  • Australia

  • 2001

  • Review

  • -

Virulence Factors Detailed description of the virulence mechanisms
  • Locht C 21

  • France

  • 1999

  • Review

  • -

Virulence mechanisms Detailed description of toxins, including molecular biology

CGPNI: General Coordination of the National Immunization Program; SVS: Secretariat of Health Surveillance; MS: Ministry of Health; DTP:triple-cell whole-cell bacterial vaccine against diphtheria, pertussis and tetanus; DTPa: diphtheria, tetanus, and pertussis adsorbed vaccine; dTpa:triple acellular bacterial for use in adolescents and adults; CDC: Centers for Disease Control and Prevention.